To Evaluate the Efficacy and Safety of KN060 in Essential Hypertension

NCT07191899 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: KN060
DRUG: 0.9% Sodium Chloride Injection

Sponsor

Suzhou Alphamab Co., Ltd.